Episode

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

Podcast
Business Of Biotech
Published
Feb 9, 2026
Duration seconds
2556
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/1011661/episodes/18624039-bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.mp3
Audio
https://www.buzzsprout.com/1011661/episodes/18624039-bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.mp3
JSON
/v1/public/podcasts/business-of-biotech-123501/episodes/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie
Markdown
/podcast/business-of-biotech-123501/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/business-of-biotech-123501/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite Pharma, a Gilead-owned company focused on curing cancer with cell therapies. Perettie talks about scaling cell therapies in the community setting, global manufacturing strategy, preparing for the launch of late-stage development programs in lymphoma and multiple myeloma, and working with partners like Ar...